Floatz logo

Neurotropin

Complex Regional Pain Syndrome Type I

National Institute of Nursing Research (NINR)Phase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Complex Regional Pain Syndrome Type I cohort.

Asset / SponsorPhaseRating
Naltrexone
Hospital for Special Surgery, New York
Phase 4BB
LIDOCAINE
Hospices Civils de Lyon
Phase 2/3B
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Hospices Civils de Lyon
Phase 2/3B
Incobotulinumtoxin-A
Bo Biering-Soerensen
N/ANR

Same molecule, other indications

Neurotropin is also rated in:

neuralgiaDormant
B
Indicative ·
56 / 100
View asset →
colorectal cancerDormant
CCC
Indicative ·
51 / 100
View asset →
complex regional pain syndrome type 2Dormant
NR
Indicative ·
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →